Other products from "CYTOPHIL, INC."
No Primary DI Version or Model Catalog Number Device Description Product Code Product Code Name Device Class Brand Name
1 00852108006411 02-100-03-VEX VX-23310 Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intended to fill bony void or gaps of the extremities, posterolateral spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure. MQV Filler, Bone Void, Calcium Compound 2 Callisto Granules Beta-TCP Synthetic Bone Graft
2 00852108006404 02-050-03-VEX VX-23305 Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intended to fill bony void or gaps of the extremities, posterolateral spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure. MQV Filler, Bone Void, Calcium Compound 2 Callisto Granules Beta-TCP Synthetic Bone Graft
3 00852108006381 02-200-02-VEX VX-12020 Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intended to fill bony void or gaps of the extremities, posterolateral spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure. MQV Filler, Bone Void, Calcium Compound 2 Callisto Granules Beta-TCP Synthetic Bone Graft
4 00852108006367 02-050-02-VEX VX-12005 Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intended to fill bony void or gaps of the extremities, posterolateral spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure. MQV Filler, Bone Void, Calcium Compound 2 Callisto Granules Beta-TCP Synthetic Bone Graft
5 00852108006206 04-010-01-SAS OST405 Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate indicated for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Osteo-i Synthetic Beta-Tricalcium Phosphate Dental Bone Graft Granules
6 00852108006190 04-005-01-SAS OST404 Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate indicated for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Osteo-i Synthetic Beta-Tricalcium Phosphate Dental Bone Graft Granules
7 00856509002935 08-015-00-V04 08-015-00-V04 Renú Gel Vocal Fold Implant is a sterile, semi-solid, cohesive implant indicated Renú Gel Vocal Fold Implant is a sterile, semi-solid, cohesive implant indicated for vocal fold medialization and vocal fold insufficiency that may be improved by injection of a soft tissue-bulking agent. MIX System, Vocal Cord Medialization 2 Renú Gel
8 00856509002294 08-015-04-V04 08-015-04-V04 Renú Calcium Hydroxylapatite Vocal Fold Implant is a sterile, semi-solid, cohesi Renú Calcium Hydroxylapatite Vocal Fold Implant is a sterile, semi-solid, cohesive implant indicated for vocal fold medialization and vocal fold insufficiency that may be improved by injection of a soft tissue-bulking agent. MIX System, Vocal Cord Medialization 2 Renú Voice
9 00852108006299 04-010-01-BSB BTCP251 Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate indicated for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Bio TCP Beta-Tricalcium Phosphate Porous Granulate
10 00856509002669 12-000-00-ND1 12-000-00-ND1 Renú Transoral Needle is a manual surgical instrument intended to deliver inject Renú Transoral Needle is a manual surgical instrument intended to deliver injectable soft tissue filling devices to the vocal folds for vocal fold medialization and/or treatment of vocal fold insufficiency that may be improved by injection of a soft tissue bulking agent. The needle is a single use device and is provided sterile and ready to use. GAA Needle, Aspiration And Injection, Disposable 1 Renú Transoral Needle
11 00852108006282 04-030-02-MIL 04-030-02-MIL Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate indicated for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Implant Logistics Synthetic Beta-Tricalcium Phosphate Dental Bone Graft Granules
12 00852108006275 04-010-02-MIL 04-010-02-MIL Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate indicated for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Implant Logistics Synthetic Beta-Tricalcium Phosphate Dental Bone Graft Granules
13 00852108006268 04-005-02-MIL 04-005-02-MIL Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate indicated for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Implant Logistics Synthetic Beta-Tricalcium Phosphate Dental Bone Graft Granules
14 00852108006251 04-030-01-MIL 04-030-01-MIL Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate indicated for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Implant Logistics Synthetic Beta-Tricalcium Phosphate Dental Bone Graft Granules
15 00852108006244 04-010-01-MIL 04-010-01-MIL Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate indicated for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Implant Logistics Synthetic Beta-Tricalcium Phosphate Dental Bone Graft Granules
16 00852108006237 04-005-01-MIL 04-005-01-MIL Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate indicated for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Implant Logistics Synthetic Beta-Tricalcium Phosphate Dental Bone Graft Granules
17 00856509002812 04-005-01-RGP 04-005-01-RGP Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate indicated for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 RegenPerio Dental Beta-TCP
18 00856509002706 02-100-02-RGO 02-100-02-RGO Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intended to fill bony void or gaps of the extremities, posterolateral spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure. MQV Filler, Bone Void, Calcium Compound 2 RegenOsteo Orthopedic Beta-TCP
19 00856509002690 02-050-02-RGO 02-050-02-RGO Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intended to fill bony void or gaps of the extremities, posterolateral spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure. MQV Filler, Bone Void, Calcium Compound 2 RegenOsteo Orthopedic Beta-TCP
20 00856509002638 02-100-03-VTX 202937-10 Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intended to fill bony void or gaps of the extremities, posterolateral spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure. MQV Filler, Bone Void, Calcium Compound 2 Trab-X SB Synthetic Bone Matrix
21 00856509002621 02-050-03-VTX 202937-05 Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intended to fill bony void or gaps of the extremities, posterolateral spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure. MQV Filler, Bone Void, Calcium Compound 2 Trab-X SB Synthetic Bone Matrix
22 00856509002584 02-050-02-VTX 102937-05 Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intended to fill bony void or gaps of the extremities, posterolateral spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure. MQV Filler, Bone Void, Calcium Compound 2 Trab-X SB Synthetic Bone Matrix
23 00852108006510 02-100-03-VTX 202937-10 Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intended to fill bony void or gaps of the extremities, posterolateral spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure. MQV Filler, Bone Void, Calcium Compound 2 Regento Regenerative Scaffold
24 00852108006329 04-030-01-PIB 04-030-01-PIB Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate indicated for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Bank-It Synthetic Beta-Tricalcium Phosphate Dental Bone Graft Granules
25 00852108006312 04-010-01-PIB 04-010-01-PIB Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate indicated for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Bank-It Synthetic Beta-Tricalcium Phosphate Dental Bone Graft Granules
26 00852108006305 04-005-01-PIB 04-005-01-PIB Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate indicated for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Bank-It Synthetic Beta-Tricalcium Phosphate Dental Bone Graft Granules
27 00852108006183 03-030-01-SAS OST413 Synthetic bone graft substitute in particulate form composed of biphasic calcium Synthetic bone graft substitute in particulate form composed of biphasic calcium phosphate intended for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Osteo-i Synthetic Biphasic Dental Bone Graft Granules
28 00852108006176 03-010-01-SAS OST402 Synthetic bone graft substitute in particulate form composed of biphasic calcium Synthetic bone graft substitute in particulate form composed of biphasic calcium phosphate intended for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Osteo-i Synthetic Biphasic Dental Bone Graft Granules
29 00852108006169 03-005-01-SAS OST401 Synthetic bone graft substitute in particulate form composed of biphasic calcium Synthetic bone graft substitute in particulate form composed of biphasic calcium phosphate intended for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Osteo-i Synthetic Biphasic Dental Bone Graft Granules
30 00852108006152 03-030-02-MIL 03-030-02-MIL Synthetic bone graft substitute in particulate form composed of biphasic calcium Synthetic bone graft substitute in particulate form composed of biphasic calcium phosphate intended for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Implant Logistics Synthetic Biphasic Dental Bone Graft Granules
31 00852108006138 03-005-02-MIL 03-005-02-MIL Synthetic bone graft substitute in particulate form composed of biphasic calcium Synthetic bone graft substitute in particulate form composed of biphasic calcium phosphate intended for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Implant Logistics Synthetic Biphasic Dental Bone Graft Granules
32 00852108006121 03-030-01-MIL 03-030-01-MIL Synthetic bone graft substitute in particulate form composed of biphasic calcium Synthetic bone graft substitute in particulate form composed of biphasic calcium phosphate intended for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Implant Logistics Synthetic Biphasic Dental Bone Graft Granules
33 00852108006114 03-010-01-MIL 03-010-01-MIL Synthetic bone graft substitute in particulate form composed of biphasic calcium Synthetic bone graft substitute in particulate form composed of biphasic calcium phosphate intended for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Implant Logistics Synthetic Biphasic Dental Bone Graft Granules
34 00852108006107 03-005-01-MIL 03-005-01-MIL Synthetic bone graft substitute in particulate form composed of biphasic calcium Synthetic bone graft substitute in particulate form composed of biphasic calcium phosphate intended for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects that are surgically created osseous defects or osseous defects created from traumatic injury to the bone. LYC Bone Grafting Material, Synthetic 2 Implant Logistics Synthetic Biphasic Dental Bone Graft Granules
35 00856509002942 02-030-02-ZVG 02-030-02-ZVG Synthetic bone graft substitute in particulate form composed of beta-tricalcium Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intended to fill bony void or gaps of the extremities, posterolateral spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure. MQV Filler, Bone Void, Calcium Compound 2 Zavation ZV Graft Beta-TCP Synthetic Bone Graft
Other products with the same Product Code "MQV"
No Primary DI Version or Model Catalog Number Device Description Brand Name Organization Name
1 04719875722318 BC-G29(2.0-3.0mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
2 04719875722301 BC-G28(2.0-3.0mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
3 04719875722295 BC-G27(2.0-3.0mm,15c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
4 04719875722288 BC-G26(1.0-2.0mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
5 04719875722271 BC-G25(1.0-2.0mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
6 04719875722264 BC-G24(1.0-2.0mm,15c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
7 04719875722257 BC-G23(0.5-1.0mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
8 04719875722240 BC-G22(1.0-2.0mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
9 04719875722233 BC-G21(2.0-3.0mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
10 04719875722226 BC-G20(2.0-3.0mm,0.25g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
11 04719875722219 BC-G19 (1.0-2.0mm,1.5g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
12 04719875722202 BC-G18(1.0-2.0mm,1.0g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
13 04719875722196 BC-G17(1.0-2.0mm,0.5g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
14 04719875722189 BC-G16(1.0-2.0mm,0.25g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
15 04719875722172 BC-G15(0.5-1.0mm,1g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
16 04719875722165 BC-G14(0.5-1.0mm,0.5g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
17 04719875722158 BC-G13(0.5-1.0mm,0.25g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
18 04719875722141 BC-G12(0.25-0.5mm,1g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
19 04719875722134 BC-G11(0.25-0.5mm,0.5g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
20 04719875722127 BC-G10(0.25-0.5mm,0.25g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
21 04719875722110 BC-G09(0.5-1.0mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
22 04719875722103 BC-G08(0.5-1.0mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
23 04719875722097 BC-G07(1.0-2.0mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
24 04719875722080 BC-G06(1.0-2.0mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
25 04719875722073 BC-G05(2.0-3.0mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
26 04719875722066 BC-G04(2.0-3.0mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
27 04719875722059 BC-G03(0.5-1.0mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
28 04719875722042 BC-G02(1.0-2.0mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
29 04719875722035 BC-G01(2.0-3.0mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
30 04719875722028 BC-B12 (5x5x10mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
31 04719875722011 BC-B11 (5x5x10mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
32 04719875722004 BC-B10 (5x5x20mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
33 04719875721991 BC-B09 (5x5x20mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
34 04719875721984 BC-B08 (5x5x20mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
35 04719875721977 BC-B07(5x5x20mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
36 04719875721960 BC-B06(5x5x20mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
37 04719875721953 BC-B05(5x5x10mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
38 04719875721946 BC-B04(5x5x10mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
39 04719875721939 BC-B03(5x5x10mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
40 04719875721922 BC-B02(5x5x10mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
41 04719875721915 BC-B01(5x5x20mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD.
42 04719875720147 BC-G29(2.0-3.0mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD. (CHUTUNG)
43 04719875720130 BC-G28(2.0-3.0mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD. (CHUTUNG)
44 04719875720123 BC-G27(2.0-3.0mm,15c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD. (CHUTUNG)
45 04719875720116 BC-G26(1.0-2.0mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD. (CHUTUNG)
46 04719875720109 BC-G25(1.0-2.0mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD. (CHUTUNG)
47 04719875720093 BC-G24(1.0-2.0mm,15c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD. (CHUTUNG)
48 04719875720086 BC-G23(0.5-1.0mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD. (CHUTUNG)
49 04719875720079 BC-G22(1.0-2.0mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD. (CHUTUNG)
50 04719875720055 BC-G20(2.0-3.0mm,0.25g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. Bicera® Resorbable Bone Substitute WILTROM CO., LTD. (CHUTUNG)